Monday, March 24, 2025 | 10:05 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Concord Drugs Share Price

Know More
BSENSE

34.74 1.15 (3.42%)

09:55 AM, 24-Mar-2025
Stock not traded

BSE : 538965

Sector : Health care

ISIN Code : INE858L01010

  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 24-Mar-2025 | 09:55 AM IST

Market Cap (₹ Cr)

35

Traded Value (₹ Cr)

0.00

Volume (Shares)

15

Face Value (₹)

10

52-Week High (₹)

44.96

52-Week High Date

26-Jun-2024

52-Week Low (₹)

26.10

52-Week Low Date

03-Mar-2025

All Time High (₹)

91.25

All Time High Date

07-Apr-2015

All Time Low (₹)

11.68

All Time Low Date

26-Mar-2020

Concord Drugs Ltd

Concord Drugs Limited established in 1995 is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals Dry Syrup powder) Tissue Bio-Adhesive tablets capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company ...
Read More

Concord Drugs Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

35

EPS - TTM (₹) [C]

0.00

P/E Ratio (X) [C]

-

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [C]33.88
P/B Ratio (₹) [C]1.03

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Data Not Found

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

34.74

34.74

Week Low/High (₹)

31.81

36.00

Month Low/High (₹)

26.10

38.00

Year Low/High (₹)

26.10

45.00

All time Low/High (₹)

11.68

91.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week2.06%-4.52%4.42%
1 Month3.83%-4.13%4.21%
3 Month-7.58%--1.21%-0.95%
6 Month-4.87%--8.70%-9.40%
1 Year0.00%-6.45%6.36%
3 Year15.80%-34.60%36.46%

Company Info

Company Information

Chairman & Managing Director : S Nagi Reddy

Independent Director : K Ramchandra Reddy

Whole Time Director & CFO : Koni Reddy

Independent Director : S. Nagavenkata Hareesh

Whole-time Director : S. Manoj Kumar Reddy

Independent Director : Summela Kasu

Company Sec. & Compli. Officer : Namratha Nagla

Registered Office: Survey No 249 Brahmanapally V, Hayathnagar M,Ranga Reddy,Telangana-501511 Ph: 91-40-24036379

Email:concorddrugsltd@gmail.com

URL:http://www.concorddrugs.in

FAQs about Concord Drugs Ltd

1. What's the Concord Drugs Ltd share price today?
Concord Drugs Ltd share price was Rs 34.74 at 09:55 AM IST on 24th Mar 2025. Concord Drugs Ltd share price was up by 3.42% over the previous closing price of Rs 33.59. Concord Drugs Ltd share price trend:

  • Last 1 Month: Concord Drugs Ltd share price moved up by 3.83% on BSE.
  • Last 3 Months: Concord Drugs Ltd share price moved down by 7.58% on BSE.
  • Last 12 Months: Concord Drugs Ltd share price moved up by 0.00% on BSE.
  • Last 3 Years: Concord Drugs Ltd share price moved up by 15.80% on BSE.


2. How can I quickly analyse the performance of the Concord Drugs Ltd stock?
The performance of the Concord Drugs Ltd stock can be quickly analysed on the following metrics:

  • Price to book value ratio is 1.03


3. What is the market cap of Concord Drugs Ltd?
Concord Drugs Ltd has a market capitalisation of Rs 35 crore.


4. What is Concord Drugs Ltd's 52-week high/low share price?
The Concord Drugs Ltd’s 52-week high share price is Rs 44.96 and 52-week low share price is Rs 26.10.


5. Is the Concord Drugs Ltd profitable?
On a consolidated basis, Concord Drugs Ltd reported a profit of Rs 0.22 crore on a total income of Rs 10.77 crore for the quarter ended 2024. For the year ended Dec 2024, Concord Drugs Ltd had posted a profit of Rs 0.23 crore on a total income of Rs 10.80 crore.


6. Which are Concord Drugs Ltd’s peers in the Health care sector?
Concord Drugs Ltd’s top 5 peers in the Health care sector are Colinz Labs, Panjon, Vineet Laborator, Concord Drugs, ANG Lifesciences, Dipna Pharmachem, Zenith Health.


7. Who owns how much in Concord Drugs Ltd?
Key changes to the Concord Drugs Ltd shareholding are as follows:

  • Promoter holding in Concord Drugs Ltd has gone down to 54.39 per cent as of Dec 2024 from 55.41 per cent as of Mar 2024.